Melatonin works as a link between circadian rhythms of different target tissues distributed on our body. The pineal gland primarily secretes melatonin, but other tissues can synthesize this hormone, while the light and darkness cycle modulates its secretion. Melatonin had a close relationship with sleep cycles and mood, but new clinical applications are now known. This hormone and its derivatives have a potent detoxifying effect, portray antioxidant properties, and play an inflammatory modulation role in multiple mechanisms.
Melatonin has multi-tasking properties that confer different regulatory actions. Indeed, this hormone binds to G-protein coupled melatonin receptors located on the plasma membrane, MT1/MT2. In turn, this binding mechanism activates molecular signaling pathways. Besides, the nuclear receptor family seems to have a high affinity for melatonin.
These high-affinity binding sites seem to play a vital role in melatonin’s antiproliferative activities on cancer cells and immunomodulation. On the other hand, melatonin’s receptor-independent signaling accounts for the radical scavenging of reactive oxygen species (ROS).
Melatonin seems to exert a blocking effect on NF-kB pathways, resulting in many different actions, either cytoprotective anti-inflammatory effects or inflammatory mechanisms.
The transcription factor, NF-kB, is dormant in the cellular cytoplasm but can activate in response to different inducers like bacterial LPS, ROS, and several cytokines. Nevertheless, in an arthritis context, the present macrophages can synthesize melatonin triggered by the NF-kB activation.
However, this mechanism can be present in the regulatory phase and chronic inflammation processes. This mechanism is possible by the same mediator induces antibodies in this autoimmune response, cReL. Therefore, it is vital to assess melatonin’s mechanism of action in rheumatoid arthritis. Studies suggest the following associations in regards to melatonin and RA:
The nutritional status of patients suffering from RA is critical. However, the body composition section of the nutritional assessment must be adapted to these patients’ needs since pain present and movement are compromised. Recently, a study on juvenile patients with idiopathic arthritis (JIA) found a correlation between phase angle, nutritional status, and JIA. Indeed, this correlation provides a deeper insight into the uses of bioelectrical impedance and phase angle.
While RA’s inflammatory mechanisms are associated with the light-dark cycle and melatonin, in OA, melatonin has therapeutic potential. The cytoprotective effects that melatonin exerts to inhibit hydrogen peroxide (H2O2)-stimulated cytotoxicity results in improved sirtuin 1 (Sirt1)
Sirt1 is an NAD+-dependent protein enzyme that influences the circadian rhythm in peripheral tissues. Following this pathway, melatonin can inhibit iNOs and COX while blocking the TNF-a, IL-1b, and IL-8 release.
Melatonin and its effects on H2O2 result in the phosphorylation inhibition of PI3K/Akt, p38, ERK, JNK, MAPK, and activation of NF-κB. Also, the intervention with melatonin in an OA rabbit model resulted in reduced cartilage destruction. In mesenchymal stem cells, melatonin exerted scavenging activities, reducing the ROS and inducing chondrogenesis mediated by MSC. Besides this, SOD activity levels were preserved presumably due to melatonin’s action.
We are going through tough times, therefore the correct information on how to manage our sleep hygiene is vital for us to manage our sleep time.
The multi-tasking hormone melatonin is a critical player in inflammatory processes and a potent antioxidant that blocks inflammatory cascades. Indeed, this information sheds light on the relevance of keeping a sleeping routine, exposure to the sun, and potential complication of nocturnal shift workers. Also, melatonin can function very differently depending on the setting in which it is present. In RA, it can promote inflammatory responses while acting as a cytoprotective agent in OA.- Ana Paola Rodríguez Arciniega, MS
Jahanban-Esfahlan, Rana et al. “Melatonin in the regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes.” British journal of pharmacology vol. 175,16 (2018): 3230-3238. doi:10.1111/bph.13898
Więch, Paweł et al. “Body composition and phase angle as an indicator of nutritional status in children with juvenile idiopathic arthritis.” Pediatric rheumatology online journal vol. 16,1 82. 27 Dec. 2018, doi:10.1186/s12969-018-0297-y
Online Appointments or Consultations:
Online Physical Injury / Accident Intake Form: https://bit.ly/Fill-Out-Your-Online-History
Online Functional Medicine Assessment: https://bit.ly/functionmed
The information herein is not intended to replace a one-on-one relationship with a qualified healthcare professional, licensed physician, and not medical advice. We encourage you to make your own health care decisions based on your research and partnership with a qualified health care professional. Our information scope is limited to chiropractic, musculoskeletal, physical medicines, wellness, sensitive health issues, functional medicine articles, topics, and discussions. We provide and present clinical collaboration with specialists from a wide array of disciplines. Each specialist is governed by their professional scope of practice and their jurisdiction of licensure.
We use functional health & wellness protocols to treat and support care for the musculoskeletal system’s injuries or disorders. Our videos, posts, topics, subjects, and insights cover clinical matters, issues, and issues that relate to and support, directly or indirectly, our clinical scope of practice.* Our office has made a reasonable attempt to provide supportive citations and has identified the relevant research study or studies supporting our posts. We provide copies of supporting research studies available to regulatory boards and the public upon request. We understand that we cover matters that require an additional explanation of how it may assist in a particular care plan or treatment protocol; therefore, to further discuss the subject matter above, please feel free to ask Dr. Alex Jimenez or contact us at 915-850-0900. Read More.
Dr. Alex Jimenez DC, MSACP, CCST, IFMCP*, CIFM*, CTG*
Licensed in Texas & New Mexico
Many of us spend a great deal of work time sitting at a desk/station every… Read More
The Kidney Disease: Improving Global Outcomes (KDIGO) and the Clinical Practice Guideline for the evaluation… Read More